Posts Tagged ‘Chief’
Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer
LENEXA, Kan. (PRWEB) December 19, 2014
B. E. Smith, the only full-service leadership solutions firm dedicated exclusively to healthcare providers, has been retained to lead a national chief financial officer search for Johnson Memorial Hospital in Franklin, Ind. The top executive search firm in the healthcare industry, B. E. Smith has recently placed more than 900 healthcare executives into organizations.
Johnson Memorial Hospital is a 100-bed, county-owned, full service hospital providing care to the residents of Johnson County and the surrounding areas. The hospital has over 100 physician and medical specialists, and recently expanded its Progressive Care and Critical Care Units, developed an advanced Surgery Center, private Maternity Suites and a growing list of outpatient and diagnostic services. Johnson Memorial Hospital implemented its “Building Excellence” cultural transformation program that allows for the establishment and monitoring of objective, quantitative goals used to determine organizational and individual performance. The program as provided overall positive staff retention rates, customer service ratings and quality metrics scores. Johnson Memorial Hospital is a member of the Johnson Memorial Health, which also includes Johnson Memorial Physician Network, Johnson Memorial Extended Services, the JMH Resource Management Company and the Johnson Memorial Hospital Foundation.
Johnson Memorial Hospital is seeking an experienced senior finance executive who will provide leadership and maximize assets in all divisions including revenue cycle, patient accounts, accounting, admissions, managed care, medical information and property leasing management. The new chief financial officer will collaborate and assist board members, medical staff members and leadership team in developing the financial component of business plans. The CFO will develop an in-depth understanding of physician employment contracts, managed care agreements and state and federal payment programs. The CFO will develop necessary forecasts and analysis for future debt issuances surrounding the hospital’s capital improvement and expansion plans. The CFO will also build the necessary relationships with other Suburban Health Organization (SHO) hospital CFOs and the Community Health Network financial team as to maximize collaboration and cost sharing opportunities. Additionally, the CFO will mentor and develop positive relationships with staff and peers, as well as build succession plans for key positions within the finance division.
The complete job posting for Johnson Memorial Hospital’s CFO position can be found on the B. E. Smith website.
About Johnson Memorial Hospital:
Johnson Memorial Hospital is a county-owned hospital located in Franklin, Indiana. The hospital has over 100 physician and medical specialists on staff, providing high quality care to the residents of Johnson County and the surrounding areas. Among the special programs available at Johnson Memorial Hospital are advanced cardiac, cancer, surgical and interventional radiology, as well as a wide range of inpatient and outpatient services. For more information about Johnson Memorial Hospital, visit http://www.johnsonmemorial.org/.
About B. E. Smith:
Founded in 1978, B. E. Smith is a full-service healthcare executive search firm and the top-ranked provider of senior-level leadership services including Interim Leadership, Executive Search and Advisory Services. Veteran healthcare recruiters and regional healthcare experts partner with each client to create customized solutions. B. E. Smith’s proven methodology has resulted in the recent placement of more than 900 leaders into healthcare organizations worldwide. The firm utilizes a comprehensive sourcing strategy incorporating the latest marketing techniques, association partnerships, social networking and one of the largest databases of skilled senior-level healthcare finance executives in the industry to deliver immediate results in today’s complex healthcare environment. For more information, visit BESmith.com or call 855-254-8261.
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Stemedica Announces New Chief Financial Officer
San Diego, CA (PRWEB) January 27, 2014
Stemedica Cell Technologies, Inc. a leader in adult allogeneic stem cell manufacturing, research and development, announced today that Craig W. Carlson has been appointed the Company’s Chief Financial Officer effective March, 2014.
Craig Carlson brings 34 years of financial, accounting, investor relations, and operational experience specifically in the biotech and biopharmaceutical industries to his role at Stemedica. Over the past 21 years of his career, Craig has played an integral role in raising over $ 420 million from private and public markets and has also had significant international experience having been responsible for various subsidiaries in China, Korea and the United Kingdom.
“Craig’s solid background in financial and accounting management along with his experience in SEC reporting, investor relations and in supporting financing initiatives in emerging growth companies is well-suited for Stemedica,” said Roger Howe, PhD, Stemedica’s Executive Chairman. “I have confidence that under Craig’s leadership, Stemedica will continue to improve our operating and financial efficiency and continue to create shareholder value.”
Previously, Craig was the Senior Vice President, Chief Financial Officer and Secretary at Talon Therapeutics, a specialty biopharmaceutical company, where he was responsible for all finance, accounting, SEC filings, information technology, and intellectual property with financial oversight on clinical trials. During his time at Talon he played an integral role in securing $ 100 million in financing; managed the Goldman Sachs mergers and acquisitions efforts; updated and streamlined Sarbanes Oxley controls and procedures; renegotiated licensing and royalty agreements, and actively participated in positioning the company for sale to Spectrum Pharmaceuticals in 2013.
He served a similar role as Senior Vice President, Chief Financial and Operating Officer as well as Managing Director U.K. for Cygnus Inc., a medical device company focused on manufacturing transdermal drug delivery systems and non-invasive glucose monitoring devices. At Cygnus, Craig supported the raise of more than $ 250 million from public and private markets as well as commercial partner payments. He also led the licensing negotiations for U.S. sales and distribution agreements as well as the national launch of the world’s first non-invasive glucose monitoring device. In addition, he initiated an aggressive investor relations marketing program that contributed to a tenfold increase in the company’s valuation. He also played a significant supporting role in the company’s sale of their transdermal patch business division to Johnson & Johnson.
During his tenure at Neurobiological Technologies, a biotech company focused on Phase III trials for Ischemic Stroke, he was instrumental in raising over $ 70 million in the midst of a difficult funding environment; successfully remedying two years of financial restatements from prior management; instituted new budgeting and cash flow forecasting systems; and led contract negotiations with CROs (Contract Research Organizations) and strategic partners.
Craig has an MBA from Stanford University Graduate School of Business, MS Ed. Counseling from Hofstra University and a BA in Political Science from Union College.
About Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. is a specialty biopharmaceutical company that is committed to the manufacturing and development of best-in-class allogeneic adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and clinical (human) trials. The company is a government licensed manufacturer of clinical grade stem cells and is approved by the FDA for clinical trials in ischemic stroke, cutaneous photoaging and acute myocardial infarction. Stemedica is currently developing regulatory pathways for a number of other medical indications using adult allogeneic stem cells. The company is headquartered in San Diego, California. http://www.stemedica.com
For more information regarding Stemedica Cell Technologies, Inc., contact Dave McGuigan at dmcguigan(at)stemedica(dot)com.
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.